Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy R van Beijnum

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|July 17, 2024
Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumorsGabriela E Wachholz, Parvin Akbari, Elisabeth J M Huijbers, et al.
Journal of Cellular and Molecular Medicine|January 24, 2014
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalizationAndrea Weiss, Judy R van Beijnum, Debora Bonvin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 17, 2023
Extracellular vimentin as a versatile immune suppressive protein in cancerKarlijn van Loon, Mathilda E van Breest Smallenburg, Elisabeth J M Huijbers, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 8, 2016
Role of the tumor stroma in resistance to anti-angiogenic therapyElisabeth J M Huijbers, Judy R van Beijnum, Victor L Thijssen, et al.
Vaccine|May 21, 2025
Guided design for the development of an evolution-proof influenza vaccineLauren Myburgh, Karlijn van Loon, Elisabeth J M Huijbers, et al.
Cancers|October 31, 2020
Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib ResistanceMagdalena Rausch, Andrea Weiss, Marloes Zoetemelk, et al.
Vaccine|May 22, 2026
Conjugate vaccine technology enhances responses to influenza virusLauren Myburgh, Karlijn van Loon, Joost Koetsier, et al.
British Journal of Cancer|December 19, 2018
Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatmentPatrycja Nowak-Sliwinska, Judy R van Beijnum, Elisabeth J M Huijbers, et al.
Vaccine|April 16, 2018
An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculatureElisabeth J M Huijbers, Judy R van Beijnum, Chung T Lê, et al.
Vaccine|June 17, 2019
Corrigendum to "An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature" [Vaccine 36(21) 3054-3060]Elisabeth J M Huijbers, Judy R van Beijnum, Chung T Lê, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta. Reviews on Cancer|July 17, 2024
Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumorsGabriela E Wachholz, Parvin Akbari, Elisabeth J M Huijbers, et al.
Journal of Cellular and Molecular Medicine|January 24, 2014
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalizationAndrea Weiss, Judy R van Beijnum, Debora Bonvin, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 17, 2023
Extracellular vimentin as a versatile immune suppressive protein in cancerKarlijn van Loon, Mathilda E van Breest Smallenburg, Elisabeth J M Huijbers, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 8, 2016
Role of the tumor stroma in resistance to anti-angiogenic therapyElisabeth J M Huijbers, Judy R van Beijnum, Victor L Thijssen, et al.
Vaccine|May 21, 2025
Guided design for the development of an evolution-proof influenza vaccineLauren Myburgh, Karlijn van Loon, Elisabeth J M Huijbers, et al.
Cancers|October 31, 2020
Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib ResistanceMagdalena Rausch, Andrea Weiss, Marloes Zoetemelk, et al.
Vaccine|May 22, 2026
Conjugate vaccine technology enhances responses to influenza virusLauren Myburgh, Karlijn van Loon, Joost Koetsier, et al.
British Journal of Cancer|December 19, 2018
Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatmentPatrycja Nowak-Sliwinska, Judy R van Beijnum, Elisabeth J M Huijbers, et al.
Vaccine|April 16, 2018
An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculatureElisabeth J M Huijbers, Judy R van Beijnum, Chung T Lê, et al.
Vaccine|June 17, 2019
Corrigendum to "An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature" [Vaccine 36(21) 3054-3060]Elisabeth J M Huijbers, Judy R van Beijnum, Chung T Lê, et al.
Pageof 7